A Study of BBI503 in Adult Patients With Advanced Hepatobiliary Cancer
Clinical trial NCT02232633 · COMPLETED
Trial details
- NCT number
- NCT02232633
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2017-12-14
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.